Tuberculosis Diagnostics Market by Manufacturers, Countries, Type and Application, Forecast to 2022
According to Stratistics
MRC, the Global Tuberculosis Diagnostics market is accounted for $2.24 billion
in 2016 and is expected to reach $3.30 billion by 2023 growing at a CAGR of
5.7% from 2016 to 2023. Increasing cases of tuberculosis is one of the major
factor responsible for high market growth. Furthermore, rising government
initiatives, growing requirement of POC in healthcare and increasing geriatric
population are some factors that are positively affecting the market. However,
lack of awareness among the patients is hindering the market.
Based on test type,
diagnostic laboratory method segment dominated the global market as they are
cost efficient and easy-to-perform. These tests also include smear microscopy
and culture-based tests. The regions with high burden rely on these
methodologies owing to their technical and financial inability to incorporate
advanced technologies.
Depending on geography, Asia Pacific region is expected to provide profitable growth over the forecast period owing to its huge population base and high burden as well the rapid proliferation of this disease. Countries such as India, China, Afghanistan, and Indonesia have been recognized as the high burden countries. Hence government agencies and WHO have planned initiatives to fortify the force of diagnostic centers including laboratories and the screening networks.
Some of the key players in this market include Siemens, F.Hoffmann-La Roche AG, BioMérieux SA, Becton, Dickinson and Company , Alere, Inc., Hain Lifesciences GmBH, Abbott Laboratories, Cepheid, Akkoni, Hologic Corporation, AutoGenomics, iCubate, MARTI TB Diagnostics, Thermo Fisher Scientific, Inc., Sanofi and Qiagen.
Depending on geography, Asia Pacific region is expected to provide profitable growth over the forecast period owing to its huge population base and high burden as well the rapid proliferation of this disease. Countries such as India, China, Afghanistan, and Indonesia have been recognized as the high burden countries. Hence government agencies and WHO have planned initiatives to fortify the force of diagnostic centers including laboratories and the screening networks.
Some of the key players in this market include Siemens, F.Hoffmann-La Roche AG, BioMérieux SA, Becton, Dickinson and Company , Alere, Inc., Hain Lifesciences GmBH, Abbott Laboratories, Cepheid, Akkoni, Hologic Corporation, AutoGenomics, iCubate, MARTI TB Diagnostics, Thermo Fisher Scientific, Inc., Sanofi and Qiagen.
Full report with Table of
Content: https://marketreportscenter.com/reports/571504/tuberculosis-diagnostics-global-market-outlook-2017-2023
End Users Covered:
• Diagnostic laboratories
• Hospitals
Test Types Covered:
• Detection of drug resistance
• Radiographic method
• Diagnostic Laboratory methods
• Detection of latent infection
• Nucleic acid testing
• Phage assay
• Mantoux Test
• Cytokine detection assay
• Other Test Types
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
• Diagnostic laboratories
• Hospitals
Test Types Covered:
• Detection of drug resistance
• Radiographic method
• Diagnostic Laboratory methods
• Detection of latent infection
• Nucleic acid testing
• Phage assay
• Mantoux Test
• Cytokine detection assay
• Other Test Types
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
…
About
Market Reports Center;
Market Reports Center is an e-commerce platform
obliging the needs of knowledge workers, experts, professionals who are subject
to market research information for their work, or to make strategic business
decisions. We are dedicated to create a comprehensive offering of market
research which is accurate, credible and affordable.
Connect
for more details:
Sam
Collins
Market
Reports Center
1-646-883-3044
(US)
Comments
Post a Comment